Gateways to Clinical Trials.
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the following tables have been retrieved from the Clinical Trials Knowledge Area of Prous Science Integrity, the drug discovery and development portal, http://integrity.prous.com. This issue focuses on the following selection of drugs: Albinterferon alfa-2b, ARRY-142886, Asenapine maleate; Bazedoxifene acetate, Bevacizumab; Caspofungin acetate, Certolizumab pegol, Custirsen sodium; Darifenacin hydrobromide; Ecogramostim, EndoTAG-1, Enzastaurin hydrochloride; HER2Bi; Lapatinib ditosylate, L-BLP-25; Micafungin sodium; O6-Benzylguanine, Odanacatib; Pazopanib hydrochloride, Pegfilgrastim, Peginterferon alfa-2a, Posaconazole; Sagopilone, Satraplatin; Tanespimycin, Tremelimumab; Vatalanib succinate, Voriconazole; Zoledronic acid monohydrate, ZP-10A.